Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Aurora Cannabis Inc. (NASDAQ: ACB) Q2 2025 Earnings Call Transcript November 6, 2024 ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial results for the fiscal 2025 second quarter. Total revenue rose year-over-year and the company has a positive outlook for the ...

Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsKevin Niland - Director, Strategic ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical marijuana segment. For instance, despite the legalization of marijuana ...

Canadian marijuana companies such as Aurora Cannabis (TSX:ACB) have created massive wealth for shareholders in the last five years. Several cannabis stocks, including Aurora Cannabis, were trading ...

Many Americans had probably never heard of Aurora, Colorado, or Springfield, Ohio, before Donald Trump broadcast his false claims about these cities nationwide late in the 2024 presidential campaign.